Up next

Autoplay

EGFR+ Non–Small Cell Lung Cancer: Frontline Options

2 Views • 07/04/23
Share
Embed
administrator
administrator
Subscribers
0

Expert Mark Socinski, MD, shares insight on the frontline systemic therapy options available for EGFR-mutant non–small cell lung cancer treatment and considers the value of multidisciplinary care in the context of brain metastases.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay